Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study.
Feliu J, Firvida JL, Castro J, Madroñal C, Rodríguez-Jaráiz A, Salgado M, Belda-Iniesta C, Casado E, García-Mata J, González-Barón M; Oncopaz Cooperative Group. Feliu J, et al. Among authors: castro j. Cancer Chemother Pharmacol. 2009 Feb;63(3):403-9. doi: 10.1007/s00280-008-0749-z. Epub 2008 Apr 9. Cancer Chemother Pharmacol. 2009. PMID: 18398610 Clinical Trial.
Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen.
Feliu J, González Barón M, Chacón JI, Espinosa E, Garrido P, Castro J, Escobar Y, Colmenarejo A, Jara C, García Girón C, Espinosa J, Ordóñez A. Feliu J, et al. Among authors: castro j. Cancer Chemother Pharmacol. 1996;38(2):191-4. doi: 10.1007/s002800050469. Cancer Chemother Pharmacol. 1996. PMID: 8616911 Clinical Trial.
Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group.
Feliu J, López Gómez L, Madroñal C, Espinosa E, Espinosa J, Girón CG, Martínez B, Castro J, De la Gándara I, Barón MG. Feliu J, et al. Among authors: castro j. Cancer. 1999 Oct 15;86(8):1463-9. doi: 10.1002/(sici)1097-0142(19991015)86:8<1463::aid-cncr12>3.0.co;2-n. Cancer. 1999. PMID: 10526274 Clinical Trial.
Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer.
Feliu J, Martín G, Madroñal C, Rodríguez-Jaráiz A, Castro J, Rodríguez A, Checa T, Bolaño M, Casado E, González-Barón M. Feliu J, et al. Among authors: castro j. Cancer Chemother Pharmacol. 2003 Sep;52(3):247-52. doi: 10.1007/s00280-003-0638-4. Epub 2003 May 29. Cancer Chemother Pharmacol. 2003. PMID: 12783203 Clinical Trial.
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
Feliu J, Martín G, Castro J, Sundlov A, Rodriguez-Jaráiz A, Casado E, Lomas M, Madroñal C, Galán A, Belda C, Gonzalez-Barón M. Feliu J, et al. Among authors: castro j. Cancer Chemother Pharmacol. 2006 Oct;58(4):527-31. doi: 10.1007/s00280-006-0198-5. Epub 2006 Mar 23. Cancer Chemother Pharmacol. 2006. PMID: 16555090 Clinical Trial.
Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.
Feliu J, Mel R, Borrega P, López Gómez L, Escudero P, Dorta J, Castro J, Vázquez-Estévez SE, Bolaños M, Espinosa E, González Barón M; Oncopaz cooperative group, Spain. Feliu J, et al. Among authors: castro j. Ann Oncol. 2002 Nov;13(11):1756-62. doi: 10.1093/annonc/mdf286. Ann Oncol. 2002. PMID: 12419748 Free article. Clinical Trial.
Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
Feliu J, Castañón C, Salud A, Mel JR, Escudero P, Pelegrín A, López-Gómez L, Ruiz M, González E, Juárez F, Lizón J, Castro J, González-Barón M; Oncopaz Cooperative Group, Spain. Feliu J, et al. Among authors: castro j. Br J Cancer. 2005 Nov 28;93(11):1230-5. doi: 10.1038/sj.bjc.6602860. Br J Cancer. 2005. PMID: 16265344 Free PMC article. Clinical Trial.
3,322 results